Mucocutaneous |
A health care worker who was splashed in the face by blood from a confirmed dengue patient was documented to have dengue infection, both identified to be DENV-3. |
1 |
Percutaneous (needle stick, laboratory injury) |
Health care workers including laboratory personnel acquired DENV infection after needlestick injuries. |
4–8 |
Blood transfusion |
Transfusion-transmitted dengue has been documented in Brazil and American Red Cross/CDC Dengue Branch; a DENV-4 outbreak in Brazil resulted in transfusion transmission in about a third of recipients of RNA-positive donations. |
9–11 |
Bone marrow transplant |
Transmission of DENV-4 in a 6-year old child from Puerto Rico via bone marrow transplant led to a fatality. |
12 |
Solid organ transplant |
DENV transmission occurred from donor to recipient after living donor liver transplantation. |
13 |
Intrapartum/perinatal |
Newborns whose mothers had acute DENV infections in the peripartum period developed dengue infection, ranging from mild febrile illness with thrombocytopenia to severe manifestations. |
14–26 |
Case reports have documented intracerebral hemorrhage and fatality in infants. |
Systematic reviews and meta-analysis found increase risk for miscarriage for women with dengue during pregnancy, preterm birth, and low birthweight. |
18–19 |
Breast milk |
A woman confirmed to have DENV infection postpartum breastfed on days 2–4 of her illness. The infant developed symptoms of dengue starting on day 4 of mother’s illness, was confirmed by PCR with high viral load in blood, and breast milk was positive by PCR and culture. |
3 |
Oronasal |
No confirmed transmission reported, but the case of mucocutaneous exposure raises possibility of oronasal infection. |
1 |
Sexual |
None reported |
- |